Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Dutasteride is a safe and effective treatment for hair loss.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Dutasteride effectively and safely treats male hair loss for over a year.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Dutasteride is becoming a popular hair loss treatment, proving more effective than finasteride with similar side effects.